Takada YU - Search Results

1

Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.

Niibe Y, Yamamoto T, Onishi H, Yamashita H, Katsui K, Matsumoto Y, Oh RJ, Aoki M, Shintani T, Yamada K, Kobayashi M, Ozaki M, Manabe Y, Yahara K, Nishikawa A, Kakuhara H, Yamamoto K, Inoue T, Takada YU, Nagata K, Suzuki O, Terahara A, Jingu K. Niibe Y, et al. Among authors: takada yu. Anticancer Res. 2020 Jan;40(1):393-399. doi: 10.21873/anticanres.13965. Anticancer Res. 2020. PMID: 31892592

2

[IIa type of early carcinoma of the ascending colon, report of a case, and studies on the series of twenty-three cases of early colorectal carcinomas].

Takada Y, Tsushimi K, Yamamoto T. Takada Y, et al. Nihon Geka Hokan. 1988 Jan 1;57(1):115-20. Nihon Geka Hokan. 1988. PMID: 3421788 Japanese. No abstract available.

3

[Nutritional assessment of postoperative gastric cancer patients using rapid-turnover proteins].

Takada Y, Tsushimi K, Hanamiya H, Yamamoto T, Fujii K, Morita N. Takada Y, et al. Nihon Geka Hokan. 1988 Jul 1;57(4):287-92. Nihon Geka Hokan. 1988. PMID: 3214231 Japanese. No abstract available.

4

Dosimetric Comparison Study of Proton Therapy Using Line Scanning versus Passive Scattering and Volumetric Modulated Arc Therapy for Localized Prostate Cancer.

Takagi M, Hasegawa Y, Tateoka K, Takada Y, Hareyama M. Takagi M, et al. Among authors: takada y. Cancers (Basel). 2024 Jan 17;16(2):403. doi: 10.3390/cancers16020403. Cancers (Basel). 2024. PMID: 38254892 Free PMC article.

5

Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy.

Someya M, Tsuchiya T, Fukushima Y, Hasegawa T, Takada Y, Hori M, Miura K, Kitagawa M, Gocho T, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Sakata KI. Someya M, et al. Among authors: takada y. Jpn J Clin Oncol. 2020 Oct 22;50(11):1290-1297. doi: 10.1093/jjco/hyaa149. Jpn J Clin Oncol. 2020. PMID: 33089868

6

Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.

Someya M, Hasegawa T, Tsuchiya T, Kitagawa M, Gocho T, Fukushima Y, Hori M, Miura K, Takada Y, Nakata K, Sakata KI. Someya M, et al. Among authors: takada y. J Radiat Res. 2020 Mar 23;61(2):265-274. doi: 10.1093/jrr/rrz099. J Radiat Res. 2020. PMID: 32009177 Free PMC article.

7

Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy.

Tsuchiya T, Someya M, Takada Y, Hasegawa T, Kitagawa M, Fukushima Y, Gocho T, Hori M, Nakata K, Hirohashi Y, Torigoe T, Saito T, Sakata KI. Tsuchiya T, et al. Among authors: takada y. Strahlenther Onkol. 2020 Aug;196(8):725-735. doi: 10.1007/s00066-019-01571-1. Epub 2020 Jan 17. Strahlenther Onkol. 2020. PMID: 31953603

8

Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy.

Takada Y, Someya M, Matsumoto Y, Satoh M, Nakata K, Hori M, Saito M, Hirokawa N, Tateoka K, Teramoto M, Saito T, Hasegawa T, Sakata KI. Takada Y, et al. Med Mol Morphol. 2016 Dec;49(4):210-216. doi: 10.1007/s00795-016-0136-5. Epub 2016 Feb 11. Med Mol Morphol. 2016. PMID: 26867665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page